Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-07, Stock:JNJ, The news for the past five days is as follows:
2018-11-29: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: Theravance Pipeline Strong, Plans Yupelri Launch by Year End.NEWS3: The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture.NEWS4: The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture.NEWS5: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS6: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS7: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture.NEWS9: Edwards Lifesciences Stock: Analysts Remain Bullish.NEWS10: [$$] New Parents Complain Amazon Baby-Registry Ads Are Deceptive.
2018-11-30: NEWS1: Understanding Array BioPharma’s Operational Performance.NEWS2: Analysts Remain Bullish on Array BioPharma Stock.NEWS3: An Overview of Array BioPharma Stock.NEWS4: Key Pharma Players With HIV Focus Ahead of World Aids Day.NEWS5: Key Pharma Players With HIV Focus Ahead of World Aids Day.NEWS6: Key Pharma Players With HIV Focus Ahead of World Aids Day.NEWS7: [$$] Best-Run U.S. Companies of 2018---and How They Got That Way.NEWS8: &apos;Shark Tank&apos; star Kevin O’Leary reveals the type of stocks that should outperform in 2019.NEWS9: Report: Developing Opportunities within Unifirst, Royal Caribbean Cruises, Albemarle, Tableau Software, Huami, and Johnson & Johnson — Future Expectations, Projections Moving into 2018.NEWS10: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS11: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS12: Theravance Pipeline Strong, Plans Yupelri Launch by Year End.NEWS13: Theravance Pipeline Strong, Plans Yupelri Launch by Year End.
2018-12-03: NEWS1: Cramer Remix: These recession-proof stocks are worth buying on a pullback.NEWS2: Health Care Sector Update for 12/03/2018: ARGX,GBT,GSK,TSRO,AGIO.NEWS3: Health Care Sector Update for 12/03/2018: ARGX,GBT,GSK,TSRO,AGIO.NEWS4: Health Care Sector Update for 12/03/2018: TSRO, GSK, VNDA, GBT, JNJ, PFE, ABT, MRK, AMGN.NEWS5: Health Care Sector Update for 12/03/2018: TSRO, GSK, VNDA, GBT, JNJ, PFE, ABT, MRK, AMGN.NEWS6: Dutch firm argenx, J&J affiliate to collaborate on cancer therapy.NEWS7: J&J to Build Blood-Cancer Push With Controversial China Biotech.
2018-12-04: NEWS1: Notable Tuesday Option Activity: JNJ, STLD, ANTM.NEWS2: Notable Tuesday Option Activity: JNJ, STLD, ANTM.NEWS3: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS4: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS5: J&J Strikes Deal with argenx to Co-Develop Cancer Antibody.NEWS6: P&G, Johnson & Johnson, Verizon Hold Strongest on Ugly Day for Dow Jones.NEWS7: Tuesday Sector Leaders: Utilities, Healthcare.NEWS8: Tuesday Sector Leaders: Utilities, Healthcare.NEWS9: Procter & Gamble, Johnson & Johnson, Verizon Climb on Ugly Day for Dow Jones.NEWS10: Better Buy: Intuitive Surgical vs. Johnson & Johnson.NEWS11: 10 Defensive Stocks to Protect Your Portfolio in 2019.NEWS12: Johnson & Johnson CEO: Fix the Drug Pricing Process, But Not Too Much.NEWS13: JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial.NEWS14: J&J's multiple myeloma drug reduces risk of death in late-stage study.NEWS15: Health Care Sector Update for 12/04/2018: CLVS, CRON, MO, PSTI, JNJ, PFE, MRK, ABT, AMGN.NEWS16: Health Care Sector Update for 12/04/2018: CLVS, CRON, MO, PSTI, JNJ, PFE, MRK, ABT, AMGN.NEWS17: Should You Be Worried About the Return of Big Pharma Deals?.NEWS18: Should You Be Worried About the Return of Big Pharma Deals?.NEWS19: The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO.NEWS20: Should You Be Worried About the Return of Big Pharma Deals?.NEWS21: Amgen antibody shows promise in myeloma trial, gets FDA fast track.NEWS22: Amgen antibody shows promise in myeloma trial, gets FDA fast track.NEWS23: Jim Cramer: Don't Throw Away These Stocks.
2018-12-06: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know.NEWS2: J&J unit to pay $360 million to U.S. to resolve charity kickback probe.NEWS3: Peninsula drug maker to pay $360M to settle Justice Department claims.NEWS4: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS5: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS6: 7 Dividend Titans Trading Like Growth Stocks.NEWS7: Houston cancer pharma co. begins Phase I trials after $6M Series B.NEWS8: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS9: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS10: Drug company Actelion to pay $360M in kickback probe.NEWS11: Noteworthy ETF Inflows: IWD, JPM, XOM, JNJ.NEWS12: Noteworthy ETF Inflows: IWD, JPM, XOM, JNJ.NEWS13: Where Does Apple Rank in the Wearables Market?.NEWS14: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS15: Dow Movers: BA, VZ.NEWS16: Dow Movers: BA, VZ.NEWS17: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS18: Health Care Sector Update for 12/06/2018: APHA, CGC, RSLS, JNJ, PFE, MRK, ABT, AMGN.NEWS19: Health Care Sector Update for 12/06/2018: APHA, CGC, RSLS, JNJ, PFE, MRK, ABT, AMGN.NEWS20: [$$] Actelion Pharmaceuticals agrees to pay $360m in DoJ settlement.

Answer: Decrease